# AI for Oracle EBS in Pharmaceuticals: Batch Genealogy, Quality Data, and Validation-Aware Design > Source: https://netray.co/erp-ai/oracle-ebs-pharmaceuticals-ai > Publisher: Netray (netray.co), AI and integration engineering for ERP and manufacturing systems. > Section: AI for ERP ## Short answer AI for Oracle E-Business Suite in pharmaceuticals gives quality, manufacturing and supply teams a private, read-only way to question batch, lot, quality-result and inventory data, with every answer tied to a visible query. It is designed to sit outside validated GxP decision paths until validated, supports data integrity principles, and does not replace EBS controls, e-signatures or QA judgement. ## Kind industry ## Erp Family oracle ## Erp Products - Oracle E-Business Suite - Oracle Process Manufacturing ## Industries - Pharmaceuticals - Life Sciences ## Region Global ## Persona Head of Quality IT ## Eyebrow Oracle EBS pharma AI ## Intro Many pharmaceutical manufacturers still run Oracle E-Business Suite, often release 12.1 or 12.2, with Oracle Process Manufacturing handling formulas, batches and quality, plus Inventory, Purchasing, Order Management and Financials around it. These systems are validated, change-controlled and slow to alter by design. That discipline is valuable. It also means that getting a new report or a new view can require a change request, impact assessment and testing cycle measured in weeks. Meanwhile the questions never stop. Quality wants every batch that used a given API lot, and every deviation tied to a supplier. Supply chain wants to know which lots will clear quarantine in time for a launch. Auditors ask for evidence of who changed what. The raw data lives in EBS tables and documents, but retrieval depends on a few people who know the schema. AI introduces its own regulatory question. In a GxP environment, anything that influences product quality decisions must be controlled and, where it does, validated under a risk-based approach such as GAMP 5. A sensible architecture therefore starts with a read-only assistant used for retrieval and analysis, kept clearly separate from the validated record and from release decisions, with humans accountable for every decision. This page describes how that works on Oracle EBS in pharma: the data involved, the guardrails, the places where EBS standard reports are enough, and what to ask any vendor, including us. ## Pain Points ### Batch genealogy across modules is slow **Detail:** Tracing from an API lot through production batches to finished lots and customers spans inventory, process execution and order data, and is often assembled by hand during investigations. ### Deviation and quality data are siloed **Detail:** Quality results, deviations and CAPAs may sit in EBS, a QMS and spreadsheets, so linking an out-of-specification result to its manufacturing context takes effort. ### Change control makes new reports expensive **Detail:** A validated environment discourages ad hoc reports, so questions queue behind formal requests. ### Audit preparation is labour intensive **Detail:** Inspection readiness needs evidence of batch history, status changes and approvals pulled from several places. ### Shortage and quarantine visibility **Detail:** Material waiting on QC release blocks production, but seeing which lots gate which orders is not a single view. ## Use Cases ### Batch and lot genealogy **Description:** Forward and backward trace from API, excipient or finished lot, with the query visible for review. **Erp Objects:** GME_BATCH_HEADER, GME_MATERIAL_DETAILS, MTL_LOT_NUMBERS, MTL_MATERIAL_TRANSACTIONS **Outcome:** Investigation preparation shortens from hours of assembly to a reviewable answer; the investigation conclusion stays with QA. ### Quality result lookup **Description:** Retrieve sample results for a lot against specification limits and flag out-of-spec or pending tests. **Erp Objects:** GMD_SAMPLES, GMD_RESULTS, GMD_SPECIFICATIONS_B, MTL_LOT_NUMBERS **Outcome:** Quicker visibility of what gates lot release; release decisions remain with the qualified person. ### Quarantine and release pipeline **Description:** Show lots awaiting QC disposition and the production or sales orders waiting on them. **Erp Objects:** MTL_ONHAND_QUANTITIES_DETAIL, lot status, WIP or batch requirements, OE_ORDER_LINES_ALL **Outcome:** Supply planners prioritise QC effort where it unblocks the most demand. ### Formula and version review **Description:** Compare recipe versions and list what changed, who approved, and which batches used each version. **Erp Objects:** FM_FORM_MST_B, FM_MATL_DTL, GMD recipe tables, change records **Outcome:** Faster, more consistent review; approval remains in the validated process. ### Inspection readiness pack **Description:** Assemble a batch history summary with status changes and linked documents for a requested lot. **Erp Objects:** Batch tables, transaction history, e-record and e-signature data where used, attachments **Outcome:** Reduces preparation time for inspections; the pack is checked by a person before it is shared. ### Supplier and material trend Q and A **Description:** Ask about incoming test failures or delivery delays by supplier and material over time. **Erp Objects:** PO_HEADERS_ALL, RCV_TRANSACTIONS, GMD_RESULTS **Outcome:** Supports supplier reviews with consistent data. ### SOP and quality document assistant **Description:** Answer procedure questions from controlled, current-version documents with citations. **Erp Objects:** Document management system, EBS attachments **Outcome:** Fewer questions to QA staff; only approved versions are indexed. ## Architecture **Overview:** The assistant is deliberately separate from the validated EBS record. It reads, explains and cites; it does not write, release or approve. **Layers:** #### Read-only data tier **Detail:** A reporting replica or Active Data Guard standby, queried with a restricted database role, so production is unaffected. #### Tested query library **Detail:** Qualified genealogy and quality queries; the model chooses and parameterises them rather than writing arbitrary SQL for regulated questions. #### Controlled document index **Detail:** Only current approved SOPs and specifications, with version and effective date. #### Model serving **Detail:** Open-weight models on local GPUs or a private cloud under change control. #### Audit and governance **Detail:** Logs of questions, queries and users, model and prompt version control, and documented intended use. ## Deployment Options ### On-prem GPU server **Fit:** Sites with strict data and network policies. **Detail:** Runs beside the EBS database tier with no outbound calls. ### Private cloud **Fit:** EBS on Oracle Cloud Infrastructure or another controlled cloud. **Detail:** Same tenancy and network, private endpoints only. ### Standby-based reporting **Fit:** Validated production where load must be avoided. **Detail:** Queries run against a standby or replica with a restricted role. ## Compliance ### The assistant does not create or modify electronic records or signatures; EBS e-records remain the system of record, and any future write step would need its own validation. **Framework:** 21 CFR Part 11 and EU Annex 11 ### Start with a read-only, non-GxP-decision use, document intended use and risk, and validate further only if use expands into regulated decisions. **Framework:** GAMP 5 risk-based validation ### Answers cite source records and queries, and logs attribute every question to a user and time. **Framework:** Data integrity (ALCOA+) ### It retrieves batch and quality information to support review; compliance and disposition stay with your quality unit. **Framework:** 21 CFR 210 and 211 ## Integration Notes - OPM table names differ by release and installed modules; confirm against your 12.1 or 12.2 data dictionary and any custom extensions. - Use the Integrated SOA Gateway or approved views for governed access rather than direct table reads wherever possible. - Use a restricted database role and a replica; never share the APPS schema credentials. - Lot status and quarantine logic often uses custom statuses; map them explicitly. - Quality results may also reside in LIMS; plan how those are joined and what is authoritative. - Treat the prompt, model and query library as controlled items under change management. ## Product Fit ### ERPray **Why:** Read-only natural-language access to EBS data with visible queries and role-aware access. ### DataRay **Why:** When LIMS, QMS and document stores must be queried together with EBS. ## Engagement ### Intended-use definition **Duration:** 1 to 2 weeks **Deliverables:** - Documented intended use and risk assessment - Question inventory from QA and supply - Data access design ### Query library **Duration:** 3 to 4 weeks **Deliverables:** - Tested genealogy and quality queries - Document index of approved SOPs - Role design ### Pilot **Duration:** 4 to 6 weeks **Deliverables:** - Pilot with QA and supply users - Accuracy test against known batches - Audit log review ### Governance **Duration:** Ongoing **Deliverables:** - Change control for models and prompts - Periodic review - Runbook handover ## Buyer Questions - Is the assistant strictly read-only, and how is that enforced? - How would you support our validation approach if use expands? - Can every answer be traced to a query and source record? - How are model and prompt changes controlled? - Can it run with no external connectivity? - How does it handle our custom lot statuses? - Who owns the audit logs? ## Faq ### Can AI be used in a GxP environment? **Answer:** Yes, with a risk-based approach. A read-only assistant used for retrieval and analysis, with humans making all decisions, carries lower risk than one that influences release. If its output feeds regulated decisions, you should assess it under your computerized system validation process. ### Does it replace our EBS reports? **Answer:** No. Standard and validated reports remain the reference. AI covers ad hoc questions that would otherwise wait for a change request. ### Will it write to Oracle EBS? **Answer:** Not in this design. Writes to a validated system would require their own validation, e-signature handling and approval, and are outside the starting scope. ### Is Oracle Process Manufacturing required? **Answer:** No, but if you use it the batch and quality tables provide the richest answers. Discrete-based plants can use WIP and Inventory data in the same way. ### What about release 12.2 versus 12.1? **Answer:** Both are workable. Table structures are largely consistent, though online patching in 12.2 adds edition-based objects to account for in queries. ### How do we avoid wrong answers? **Answer:** Use a tested query library for regulated questions, show queries, require citations, and measure accuracy on a test set before go-live. ### Where does data stay? **Answer:** On your infrastructure. Models, retrieval and logs are local, and no public AI service is called. ## Search terms Oracle EBS pharmaceuticals, Oracle Process Manufacturing pharma, Oracle EBS GxP AI, Oracle EBS batch genealogy, 21 CFR Part 11 Oracle EBS, AI for pharmaceutical ERP, OPM quality results report, Oracle EBS 12.2 life sciences, private AI pharma manufacturing, Oracle EBS lot traceability --- Talk to an engineer: https://netray.co/contact?intent=erp_ai | Machine catalog: https://netray.co/agent/catalog.json